Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clotrimazole buccal tablets vs clotrimazole troche for oropharyngeal candidiasis (Phase III, China)
CTR20221412Phase 3Completed
- Sponsor
- Jiangsu Yabang Johnson Pharmaceutical
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clotrimazole in oral candidiasis, sponsored by Jiangsu Yabang Johnson Pharmaceutical. Started Jun 2022; status: completed.
02
Drugs
clotrimazole
03
Conditions
oral candidiasis
Beyond the preview
Go deeper on CTR20221412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221412.